Organic anion-transporting polypeptide (OATP) transporter family and drug disposition.
about
Near IR heptamethine cyanine dye-mediated cancer imagingFruit juice inhibition of uptake transport: a new type of food-drug interactionClinical pharmacokinetics and pharmacodynamics of the endothelin receptor antagonist macitentanRole of OATP-1B1 and/or OATP-1B3 in hepatic disposition of tyrosine kinase inhibitorsInhibition of OATP-1B1 and OATP-1B3 by tyrosine kinase inhibitorsGender-specific expression of liver organic anion transporters in rat.Expression of human solute carrier family transporters in skin: possible contributor to drug-induced skin disorders.Genetic Determinants of the Pharmacokinetic Variability of Rifampin in Malawian Adults with Pulmonary Tuberculosis.Oatp1 enhances bioluminescence by acting as a plasma membrane transporter for D-luciferinEffect of cyclosporine and rifampin on the pharmacokinetics of macitentan, a tissue-targeting dual endothelin receptor antagonist.Influence of dietary substances on intestinal drug metabolism and transport.Identification of novel functional organic anion-transporting polypeptide 1B3 polymorphisms and assessment of substrate specificity.Podocyte expression of membrane transporters involved in puromycin aminonucleoside-mediated injuryConsensus report of the 4th International Forum for Gadolinium-Ethoxybenzyl-Diethylenetriamine Pentaacetic Acid Magnetic Resonance ImagingThe SLCO1B1 rs4149032 polymorphism is highly prevalent in South Africans and is associated with reduced rifampin concentrations: dosing implications.Inhibition of the organic anion-transporting polypeptide 1B1 by quercetin: an in vitro and in vivo assessment.Mechanisms underlying food-drug interactions: inhibition of intestinal metabolism and transport.Endocrine and metabolic regulation of renal drug transporters.Drug interactions in cancer therapy.Grapefruit-drug interactions: can interactions with drugs be avoided?The different effects of itraconazole on the pharmacokinetics of fexofenadine enantiomers.Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs.HIV protease inhibitors are substrates for OATP1A2, OATP1B1 and OATP1B3 and lopinavir plasma concentrations are influenced by SLCO1B1 polymorphismsDrug resistance in cancer - searching for mechanisms, markers and therapeutic agents.Influence of drug transport proteins on the pharmacokinetics and drug interactions of HIV protease inhibitors.Organic anion uptake by hepatocytes.Enantioselective disposition of fexofenadine with the P-glycoprotein inhibitor verapamil.Interaction of macrolide antibiotics with intestinally expressed human and rat organic anion-transporting polypeptides.Analysis of drug interactions involving fruit beverages and organic anion-transporting polypeptides.Clinical pharmacokinetics of fexofenadine enantiomers.Cyanobacterial toxins and liver disease.Impact of drug transporter pharmacogenomics on pharmacokinetic and pharmacodynamic variability - considerations for drug development.The pharmacology of novel oral anticoagulants.α-Tocopheryl Phosphate as a Bioactive Derivative of Vitamin E: A Review of the Literature.Small molecule membrane transporters in the mammalian podocyte: a pathogenic and therapeutic target.Effect of OATP-binding on the prediction of biliary excretion.Review article: The pharmacokinetics and pharmacodynamics of drugs used in inflammatory bowel disease treatment.Resveratrol and its major sulfated conjugates are substrates of organic anion transporting polypeptides (OATPs): impact on growth of ZR-75-1 breast cancer cells.Food and Drug Interactions.Role of drug efflux and uptake transporters in atazanavir intestinal permeability and drug-drug interactions.
P2860
Q24616262-6AC76E48-103E-4893-B628-1FA1C4DED724Q24630998-37753FF7-DF07-4041-966F-2B2D7EA9D6D4Q26851546-B9754AA9-1F21-4922-BAE9-BCDCA61A4730Q28236180-2D16DC73-A384-4A98-8772-67626A5455B8Q28239708-02283E60-9619-4690-847E-A756D48D6915Q33223825-87CEEAF9-BC5B-4C77-A8F7-C081CECD28CDQ33737892-EAB4718E-D02F-44A6-A5DE-6093B1F64033Q33843657-220F7423-3898-4CC7-B312-0C362B54141EQ34169354-1C11BD03-F3CF-4987-B4C5-6D1AEB987747Q34242199-1CB7D50F-A5FF-4C26-B603-127AACF882D4Q34553835-F678B73D-8549-47C3-873C-B6D343D07734Q34603829-2814DCE2-9E37-488A-8B50-8302BE65AFA1Q34805111-336A921A-227B-4EC5-BA19-72B3FB61587FQ35148664-7D967C31-4025-4E47-A1FA-2C73D1355B73Q35191432-F23388EC-3FD6-42DB-8123-90D5956A2227Q36111214-8F1A6A19-3EAB-4F9A-B050-073193D0704FQ36303746-D0076797-BB01-47C8-BB05-8AD393F2E844Q36335726-9B074C1A-D4B5-4126-A934-2E61F0B79CDDQ36516421-14FE2396-C5DA-4A35-96D5-4A389219B2F1Q36652594-2D92C90E-93D1-4B69-8083-F7C3D1A55202Q36729143-57F7963D-F934-43C6-BCCD-71E4AA876ED4Q36748145-C8EF4D1E-9255-4F99-981F-DA111FE7A9D9Q36877910-704C7568-56FC-41F1-ACED-6E187F5A63C5Q37008882-CD3EF1EF-F278-40B2-BD60-368E7EF42F8AQ37113947-029AA039-1030-4552-A3F1-3A57F42D5568Q37137527-38FE5AAF-CF1A-4036-A61C-652A89C7D157Q37201689-ECABEE59-CDCF-4CA0-9C9A-180833BA00CDQ37444375-2A3D2BDA-B296-42F6-B1B8-5033004006E9Q37605463-AC68F84A-7BF1-4E3C-81AD-2BFA64C55E11Q37641373-ADA1CB10-5BB5-475B-BA86-01E5F28A098DQ37669193-A456F46D-9D2D-4861-B2E2-76CA617B2E7CQ38003174-196FA337-EDE5-468D-9DA2-EA715DB20FD8Q38122099-96A4CFFD-36E0-4F42-A8CE-9C672F6800B7Q38252630-8F4F1C6C-18A7-42FB-8F75-1930CF6BFBA9Q38269878-DE528864-024F-4D73-8B1A-FF55B0A1E92CQ38436729-2026C2F7-B8A3-4E79-941E-0F99F497239DQ38501680-75521656-4199-4A12-B80D-97F2EC225625Q38977944-E222E6E1-E162-49E4-862F-3A138F6EA022Q39162829-833CB944-2BCC-4CE5-BA7E-851C7632AAE4Q39229674-E8A43CAA-A6DD-42C9-A150-7B43B0413844
P2860
Organic anion-transporting polypeptide (OATP) transporter family and drug disposition.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Organic anion-transporting polypeptide (OATP) transporter family and drug disposition.
@ast
Organic anion-transporting polypeptide (OATP) transporter family and drug disposition.
@en
type
label
Organic anion-transporting polypeptide (OATP) transporter family and drug disposition.
@ast
Organic anion-transporting polypeptide (OATP) transporter family and drug disposition.
@en
prefLabel
Organic anion-transporting polypeptide (OATP) transporter family and drug disposition.
@ast
Organic anion-transporting polypeptide (OATP) transporter family and drug disposition.
@en
P1476
Organic anion-transporting polypeptide (OATP) transporter family and drug disposition.
@en
P2093
P356
10.1046/J.1365-2362.33.S2.5.X
P478
33 Suppl 2
P577
2003-11-01T00:00:00Z